← Open Payments lookup

GUILFORD HURST: Open Payments

NPI 1467779256 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$12,982 in 58 payments from 8 companies in 2025. Trend: 2023 $12,693 · 2024 $9,551 · 2025 $12,982

Speaker / faculty: $6,750Consulting: $4,380Food & beverage: $1,106Travel & lodging: $746
CompanyPaymentsAmount
Alkermes, Inc.27$12,433
E.R. Squibb & Sons, L.L.C.12$145
Otsuka America Pharmaceutical, Inc.6$138
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$72
Neurocrine BioSciences, Inc.3$63
Lundbeck LLC3$56
Teva Pharmaceuticals USA, Inc.2$45
ABBVIE INC.2$30

Products named: LYBALVI, COBENFY, REXULTI, ARISTADA, CAPLYTA, INGREZZA, ABILIFY ASIMTUFII, VRAYLAR.

Industry payments across DE — which companies pay providers there.